Skip to main content
U.S. flag

An official website of the United States government

Healthcare

Federal Announcements

NIST Awards Over $1.2 Million to Small Businesses to Advance Cybersecurity, Biopharmaceuticals, Semiconductors and More

| Department of Commerce (DOC), National Institute of Standards and Technology (NIST) | Cybersecurity, Healthcare, Research and Development (R&D), Semiconductors, Small and Medium-sized Manufacturers

The U.S. Department of Commerce’s National Institute of Standards and Technology has awarded more than $1.2 million to 12 small businesses in eight states under the Small Business Innovation Research Program. The awards will fund research and development of new products relating to cybersecurity, quantum computing, health care, semiconductor manufacturing and other critical areas.

Read more

Related Programs

  • Advanced Regenerative Manufacturing Institute (ARMI)

    Agency:
    Department of Defense (DoD)
    Topics:
    Bioeconomy, Healthcare, Workforce

    The Advanced Regenerative Manufacturing Institute (ARMI), a Manufacturing USA Institute, is a member-based, nonprofit organization whose mission is to advance the bioeconomy of the United States. The institute’s work will positively impact not only manufacturing but also healthcare and education & workforce development for the nation. 

    Visit

  • BioFabUSA

    Agency:
    Department of Defense (DoD)
    Topics:
    Healthcare, Manufacturing USA, Technology, Workforce

    BioFabUSA, a Manufacturing USA Institute and program of the Advanced Regenerative Manufacturing Institute (ARMI), is a public-private partnership including companies, academic institutions and not-for profit organizations. The mission of BioFabUSA is to bring together the fundamental tenets of good manufacturing processes and the science of regenerative medicine to create regenerative manufacturing and the trained and ready workforce necessary for that manufacturing.

    Visit

  • Biomedical Advanced Research and Development Authority – Pharmaceutical Countermeasures Infrastructure (PCI)

    Agency:
    Department of Health and Human Services (DHHS)
    Topics:
    Biomedical, Healthcare, Research and Development (R&D)

    A strong, committed partnership between industry and the federal government is vital when responding to a public health emergency. Through the work of its three programs, PCI partners with industry to strengthen and enhance the nation’s ability to manufacture, distribute, and administer life-saving vaccines and therapeutics during a public health emergency.

    Visit

  • National Biopharmaceutical Manufacturing Preparedness Consortium (BioMap-Consortium)

    Agency:
    Department of Health and Human Services (DHHS)
    Topics:
    Biomedical, Healthcare, Research and Development (R&D), Supply Chain, Technology

    The Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP-Consortium) supports the Biomedical Advanced Research and Development Authority (BARDA) and is comprised of industry partners across the drug and vaccine manufacturing supply chain, including manufacturers of required raw materials and consumables, developers of innovative manufacturing technologies, and suppliers of fill finish services. This consortium seeks to expand the industrial and manufacturing base for medical countermeasures to include the requisite capabilities, flexibilities, and strategies to secure needed medical supplies to meet the nation’s public health preparedness and response requirements.

    Visit

Related Reports

  • Policy Considerations to Prevent Drug Shortages and Mitigate Supply Chain Vulnerabilities in the United States

    | Healthcare, Supply Chain

    This paper describes policy concepts for consideration, including collaboration with the private sector to develop and implement a Manufacturer Resiliency Assessment Program (MRAP) and a Hospital Resilient Supply Program (HRSP).

    Read report

  • First Annual Report on Progress Towards Implementation of the American Pandemic Preparedness Plan

    | COVID-19, Healthcare, Medical and Pharmaceutical

    This document, released on the one-year anniversary of the public release of American Pandemic Preparedness: Transforming our Capabilities, provides the first annual report outlining progress towards implementation of relevant capabilities, highlights priority actions that are ongoing and needed across departments and agencies in the U.S. Government and the private sector, and identifies S&T opportunities to fill gaps and ensure that the Nation is properly prepared for emerging pandemic threats

    Read report

  • Public Health Supply Chain and Industrial Base: One-Year Report In Response to Executive Order 14017

    | COVID-19, Healthcare, Supply Chain

    The Coronavirus Disease 2019 (COVID-19) pandemic has significantly tested the U.S. public health supply chain and industrial base. It has strained global supply chains and exposed critical vulnerabilities in the Nation’s ability to deliver effective health care during times of high demand. Despite the challenges encountered since early 2020, the United States has made great progress to strengthen the public health supply chain and to address concerns regarding domestic manufacturing.

    Read report